Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0.0512820512820511 0.0512820512820511
Stock impact report

BRIEF-Affimed presents data from Phase 1B combination study of AFM13 with pembrolizumab at Ash [Reuters]

Affimed N.V. (AFMD) 
Last affimed n.v. earnings: 11/19 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: affimed.com/investor-relations.php
Company Research Source: Reuters
BRIEF-Affimed presents data from Phase 1B combination study of AFM13 with pembrolizumab at Ash | Reuters Reuters Staff 1 Min Read Dec 11 (Reuters) - Affimed Nv: * Affimed presents data from Phase 1B combination study of AFM13 with Pembrolizumab at Ash * Affimed NV - completed dose-escalation shows combination of AFM13 and pembrolizumab is well-tolerated * Affimed - 3-month ORR compares favorably to historical ORR of pembrolizumab alone in Phase 1B combination study of aFM13 * Affimed NV - one dose-limiting toxicity observed in Cohort 3, which was repeated GRADE 2 infusion-related reaction * Affimed NV - In Cohort 3, repeated Grade 2 infusion-related reaction lead to discontinuation of AFM13 treatment Source text for Eikon: Further company coverage: All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. © 2017 Reuters. All Rights Reserved. BRIEF-Affimed presents data from Phase 1B combination study of AFM13 with pembrolizumab at Ash D Show less Read more
Impact Snapshot
Event Time:
AFMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AFMD alerts
Opt-in for
AFMD alerts

from News Quantified
Opt-in for
AFMD alerts

from News Quantified